Register entry

Mycovia Pharmaceuticals, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
1
Live patents
5
Exclusivities
1
Countries
0
Exclusivity

Patents and exclusivities

5
PatentProductCoversExpiry
8236962VIVJOAoteseconazolesubstance, productApr 2031
8754227VIVJOAoteseconazoleuseApr 2031
11247981VIVJOAoteseconazoleuseMay 2033
10414751VIVJOAoteseconazolesubstance, productMar 2036
9840492VIVJOAoteseconazolesubstance, productMar 2036
ProductExclusivityUntil
VIVJOAOTESECONAZOLEGAIN Qualified infectious disease product (GAIN)Apr 2032
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
VIVJOAoteseconazolecapsule, oral74695-823NDA
Enquiry

Common questions

Is Mycovia Pharmaceuticals, Inc. FDA approved?
Mycovia Pharmaceuticals, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Mycovia Pharmaceuticals, Inc. make?
1 product is listed under Mycovia Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.